| Oct 15 |
Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52%
|
| Oct 11 |
Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe
|
| Oct 9 |
Xenon Pharmaceuticals Inc (XENE) Q2 2024 Earnings Call Highlights: Strategic Advances and ...
|
| Oct 2 |
Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference
|
| Sep 9 |
Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress
|
| Sep 5 |
Xenon Pharmaceuticals Inc. (XENE): Among the Best Mid-Cap Healthcare Stocks To Buy Now
|
| Aug 26 |
We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely
|
| Aug 21 |
Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe
|
| Aug 12 |
Xenon names Matthew Ronsheim as chief operating officer
|
| Aug 12 |
Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
|
